利波卡林-2通过肺癌中瘤与微环境的相互相互作用驱动大脑转移的进展
Yixiang Zhu1,2, Jian Zhang1, Danming He1,3
1State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Signal transduction and targeted therapy
|December 23, 2025
概括
利波卡林-2 (LCN2) 通过促进瘤细胞和免疫细胞相互作用,驱动肺癌中大脑转移. 用SH4-54等抑制剂向LCN2-JAK2/STAT3轴显示出治疗大脑转移的前景.
科学领域:
- 在瘤学瘤学.
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
背景情况:
- 大脑转移是肺癌患者的主要死亡原因.
- 大脑独特的微环境会影响转移,但分子机制尚不清楚.
- 利波卡林-2 (LCN2) 与癌症进展有关.
研究的目的:
- 阐明LCN2在肺癌脑转移 (BM) 中的作用.
- 研究LCN2介导的瘤细胞,星细胞和巨细胞之间的相互作用.
- 评估针对 BM 中 LCN2 途径的治疗策略.
主要方法:
- 在肺癌BM的小鼠模型中研究了LCN2信号.
- 利用细胞共同培养系统研究瘤-免疫细胞交叉交流.
- 使用向IL-1受体 (anakinra) 和STAT3 (SH4-54) 的抑制剂,以及抗VEGF治疗 (bevacizumab).
主要成果:
- 瘤分泌的LCN2通过SLC22A17激活星细胞,促进巨细胞的招募.
- 巨细胞衍生的IL-1β进一步增强瘤细胞中的LCN2表达.
- STAT3抑制 (SH4-54) 和IL-1受体阻塞协同减少了BM瘤的生长.
- LCN2还对瘤细胞起作用,激活JAK2 / STAT3,上调VEGF-A,并促进新血管化.
- 在BM小鼠中,SH4-54,贝瓦齐祖马布或组合疗法减少了瘤负担.
结论:
- LCN2是肺癌脑转移的关键调解者.
- LCN2星细胞-巨细胞轴和LCN2瘤细胞轴是BM的关键驱动因素.
- 针对JAK2/STAT3通路和LCN2信号提供了一个潜在的治疗策略,用于大脑转移性肺癌.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
02:30Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K